It's a shot in the arm for Cambridge, Massachusetts-based Moderna as it faces an evolving regulatory environment for vaccines ...

RNA-1010 demonstrated superior relative vaccine efficacy that was 26.6% (95% CI; 16.7%, 35.4%) higher than a licensed ...

Doctors in Massachusetts are seeing more children end up in the hospital with flu-related brain complications. It’s not yet clear from national data whether the number of serious flu-related ...

As fired and retired scientists rallied outside in the Atlanta heat, an advisory panel that Robert F. Kennedy Jr. handpicked ...

Nantucket is the latest community to start testing its sewage for drugs — partnering with a Cambridge firm that analyzes ...

mRNA-1010 demonstrated superior relative vaccine efficacy that was 26.6% (95% CI; 16.7%, 35.4%) higher than a licensed standard-dose seasonal influenza vaccine in adults aged 50 years and older ...

Phase 2 protocol submitted to HREC to evaluate tivoxavir marboxil (TXM) in a combined seasonal and bird flu study in the Southern Hemisphere Briefing documents submitted to FDA for a Type D meeting ...

The last thing Lowell High assistant track coach Bobby Panagiotopoulos remembers the morning of May 13 is the family dog, Leo, licking his face. He woke up 37 days later to his world ...

Open Streets Capitol Hill celebrated community engagement, wellness, and economic empowerment, offering a car-free cultural ...

Uy said he wanted to file a bill granting free flu vaccines for senior citizens. “I want all the senior citizens to get their flu vaccines. As it is, the flu vaccines are only given while supply lasts ...

The Cambridge biotech believes packaging the two immunizations together will lead to higher uptake of COVID vaccines.